No Detail Found!

Pioneering Efforts: Cardiac Device Implantation Trends and Variable Patient Outcomes - A Community Benefit Tool

Author(s)
Ghulam Kubra National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Deebaj Nadeem National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Faiza Sikandari National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Reema Qayoom National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Muhammad Sarim Ansari National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Ghazala Irfan National Institute of Cardiovascular Diseases (NICVD),Karachi,Pakistan
Abstract
Objectives: To analyze trends in cardiac device implantation and interventions, along with patient outcomes, at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan. Methodology: This retrospective study was conducted from January 2017 to December 2020 at NICVD, Karachi. Patients presenting to outpatient or emergency departments with diagnoses of bradycardia (sinus node dysfunction or atrioventricular blocks), heart failure, survival of sudden cardiac death (SCD), or cardiomyopathy, and meeting the American College of Cardiology (ACC)/American Heart Association criteria for device-based therapies, were included. Data on demographic characteristics, comorbid conditions, device types, indications, and post-procedural outcomes, including complications and mortality, were collected and analyzed. Results: A total of 5,166 cases were analyzed over the four-year study period, with 2,991 (57.9%) males and a mean age of 58.2 ± 22.4 years. Hypertension was the most prevalent comorbidity, affecting 1,872 (36.2%) patients. Dual-chamber, rate-modulated pacemakers (DDDR) were the most frequently implanted devices, accounting for 1,943 (37.6%) cases, while single-chamber implantable cardiac defibrillators (ICDs) were predominantly used for secondary prevention in ischemic heart disease. Complete heart block was the most common indication, observed in 1,794 (34.7%) patients. Post-procedural complications were infrequent, with hematoma and wound infections being the most common. Mortality was reported in 23 (0.4%) patients. Conclusion: Dual-chamber, rate-modulated pacemakers (DDDR) emerged as the most frequently implanted pacemakers, while single-chamber ICDs were the preferred defibrillators for secondary prevention. Complete heart block was the leading indication for device implantation. Post-procedural complications, including hematoma and wound infection, were rare, and overall mortality associated with cardiac device implantation was remarkably low.
Publication Details
Page(s) 297-303
Published Journal: Pakistan Heart Journal, Volume: 57, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Pakistan, Mortality, Hypertension, Ischemic heart disease, pacemaker, Cardiac devices
References
WF DeForge .2019 .Cardiac pacemakers: a basic review of the history and current technology. J Vet Cardiol, 22 : 40-50.
Dretzke J,Lip G,Raftery J,Toff W. .2001 .Dual versus Single Chamber Pacemaker Therapy for Atrioventricular Block and Sick Sinus Syndrome. , : .
Mond HG,Crozier I. .2015 .Heart Lung Circ. , 24(3) : 291-7.
Sanfins V .2019 .Implantation of resyndchronization and/or defibrillation devices in patients with heart failure: Real-life data from the Sincrone study. Rev Port Cardiol, 38(1) : 43-4.
Chia PL,Foo D. .2016 .Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management. Singapore Med, 57(7) : 354-9.
Miller JD,Yousuf O,Berger RD .2015 .The implantable cardioverterdefibrillator: An update. Trends Cardiovasc Med, 25(7) : 606-11.
Wang N,Xie A,Tjahjono R,Tian DH,Phan S,Yan TD .2017 .Implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: an updated systematic review and metaanalysis of outcomes and complications. Ann Cardiothorac Surg, 6(4) : 298-306.
Bostwick JM,Sola CL .2007 .An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am, 30(4) : 677-88.
'Brien O,Park T,Youn MS,Chung JC,ES JC .2019 .The Past, Present and Future of Cardiac Resynchronization Therapy. Korean Circ J, 49(5) : 384-99.
Okamura H .2017 .Up-to-date cardiac resynchronization therapy. J Gen Fam Med, 18(5) : 195-9.
Gadler F,Valzania C .2015 .Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter‐defibrillator registry. Europace, 17(1) : 69-77.
Fernández Lozano I,Osca Asensi J,Alzueta Rodríguez J. Spanish Implantable J .2018 .. Rev Española Cardiol, 71(12) : 1047-58.
Lazarus A,Biondi N,Thébaut J‐F,Durand‐Zaleski I,Chauvin M. .2011 .Implantable cardioverter‐defibrillators in France: practices and regional variability. Europace, 13 : 1568-73.
Masoudi FA,Ponirakis A,de Lemos JA,Jollis JG,Kremers M,Messenger JC .2017 .Trends in U.S. cardiovascular care. J Am Coll Cardiol, 69(11) : 1427-50.
Køber L,Thune JJ,Nielsen JC,Haarbo J,Videbaek L,Korup E .2016 .Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med, 375(13) : 1221-30.
Tuppin P,Neumann A,Marijon E,de Peretti C,Weill A,Ricordeau P .2011 .Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (. Arch Cardiovasc Dis, 104(5) : 332-42.
Shah B,Saidullah S,Niaz AM .2021 .Where Do We Stand?. Ann Pak Inst Med Sci, 17(2) : 206-10.
Kubra G.,Hasan F.,Qadir F.,Rasheed S,Shafquat A .2021 .Myths and misperceptions in pacemaker patients: a quasi experimental study to assess effect of an educational intervention. Int J Arrhythm, 22 : 10.
Shenthar J,Bohra S,Jetley V,Vora A,Lokhandwala Y,Nabar A .2016 .A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society. , 68(1) : 68-71.
Sandhu A,Bao H,Minges KE,Varosy PD,Borne RT,Zipse MM .2019 .Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals. JAMA Cardiol, 4(8) : 804-9.
Al Kandari F,Erglis A,Sweidan R,Dannheimer I,Sepsi M,Bénézet J .2014 .Regional variations in baseline characteristics of cardiac rhythm device recipients: The PANORAMA observational cohort study. Int J Cardiol Heart Vessel, 4 : 90-6.
0

Citations

0

Downloads

72

Views